Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2601-2609

  Ray, Alpana ^a,b   Shakya, Arvind ^a   Kumar, Deepak ^a   Benson, Merrill D ^c   Ray, Bimal K ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; AZO COMPOUND; AZOCASEIN; CASEIN; PROTEIN DERIVATIVE; SERUM AMYLOID A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SAF 1; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; AMYLOIDOSIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSING SPONDYLITIS; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DNA BINDING; FAMILIAL MEDITERRANEAN FEVER; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; LIVER; MOUSE; NONHUMAN; ORGAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SPLEEN; TRANSGENIC MOUSE;

EID: 33746893443     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2601     Document Type: Article

References (50)

1. Sipe, J. D. 1994. Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31: 325-324.
2. Kisilevsky, R. 2000. Amyloidogenesis - unquestioned answers and unanswered questions. J. Struct. Biol. 130: 99-108.
3. Cooper, J. H. 1974. Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized loluidine blue, and iodine methods. Lab Invest. 31: 232-238.
4. Rosenthal, C. J., E. C. Franklin, B. Frangione, and J. Greenspan. 1976. Isolation and partial characterization of SAA - an amyloid-related protein from human serum. J. Immunol. 116: 1415-1418.
5. Betts, J. C., M. R. Edbrooke, R. V. Thakker, and P. Woo. 1991. The human acute-phase serum amyloid A gene family: structure, evolution, and expression in hepatoma cells. Scand. J. Immunol. 34: 471-482.
6. Whitehead, A. S., M. C. deBeer, D. M. Steel, M. Rits, J. M. Lelias, W. S. Lane, and F. C. deBeer. 1992. Identification of novel members of the serum amyloid A protein super family as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 267: 3862-3867.
7. Kluve-Beekerman, B., M. L. Drumm, and M. D. Benson. 1991. Non-expression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol. 10: 651-661.
8. Sipe, J. D. 1999. Revised nomenclature for serum amyloid A (SAA). Amyloid 6: 67-70.
9. Lowell, C. A., D. A. Potter, R. S. Stearman, and J. F. Morrow. 1986. Structure of the murine serum amyloid A gene family. Gene conversion. J. Biol. Chem. 261: 8442-8452.
10. Uhlar, C. M. and A. S. White-head. 1999. Serum amyloid A. the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523.
11. Ray, A., and B. K. Ray. 1994. Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-β and C/EBP-δ and their activation by phosphorylation. Mol. Cell. Biol. 14: 4324-4332.
12. Huang, J. H., and W. S. Liao. 1994. Induction of the mouse serum amyloid A3 gene by cytokines requires both C/EBP family proteins and a novel constitutive nuclear factor. Mol. Cell. Biol. 14: 4475-4484.
13. Edbrooke, M. R., D. W. Burt, J. K. Cheshire, and P. Woo. 1989. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor κB-like transcription factor. Mol. Cell. Biol. 9: 1908-1916.
14. Li, X., and W. S. Liao. 1992. Cooperative effects of C/EBP-like and NF κ B-like binding sites on rat serum amyloid A1 gene expression in liver cells. Nucleic Acids Res. 20: 4765-4772.
15. Ray, A., M. Hannink, and B. K. Ray. 1995. Concerted participation of NF-κ B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 270: 7365-7374.
16. Ray, A., and B. K. Ray. 1996. A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells. Mol. Cell. Biol. 16: 1584-1594.
17. Ray, A., and B. K. Ray. 1998. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter. Mol. Cell. Biol. 18: 7327-7335.
18. Ray, A., and B. K. Ray. 1999. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, NF κ B, and C/EBP transcription factors. J. Immunol. 163: 2143-2150.
19. Ray, A., Kumar, D., Shakya, A., Brown, C. R., Cook, J. L., and Ray, B. K. 2004. Serum amyloid activating factor-1 transgenic mice are prone to develop a severe form of inflammation-induced arthritis. J. Immunol. 173: 4684-4691.
20. Puchtler, H., F. Sweat, and M. Levine. 1962. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10: 355-354.
21. Botto, M., P. N. Hawkins, C. M. Bickerstaff, J. Herbert, A. E. Bygrave, A. McBride, W. L. Hutchinson, G. A. Tennent, M. J. Walport, and M. B. Pepys. 1997. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat. Med. 3: 855-859.
22. Ray, A., K. Kuroki, J. L. Cook, B. S. Bal, K. Kenter, G. Aust, and B. K. Ray. 2003. Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum. 48: 134-145.
23. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
24. Sambrook, J., and D. W. Russell. 2001. Molecular Cloning: A Laboratory Manual. 3rd Ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
25. Meek, R. L., and E. P. Benditt. 1986. Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164: 2006-2017.
26. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
27. Ray, B. K., R. Murphy, P. Ray, and A. Ray. 2002. SAF-2, a splice variant of SAF-1 acts as a negative regulator of transcription. J. Biol. Chem. 277: 46822-46830.
28. Wohlgethan, J. R., and E. S. Cathcart. 1981. Amyloidosis in (CBA/J × A/J)F2 mice: correlation of amyloid resistance and low mitogenic response to concanavalin A. J. Immunol. 127: 1003-1007.
29. Janigan, D. T., and R. L. Druet. 1966. Experimental amyloidosis. Role of antigenicity and rapid induction. Am. J. Pathol. 48: 1013-1025.
30. Ray, A., and B. K. Ray. 1997. Serum amyloid A gene expression level in liver in response to different inflammatory agents is dependent upon the nature of activated transcription factors. DNA Cell Biol. 16: 1-7.
31. Ray, B. K., and A. Ray. 1997. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 36: 4662-4668.
32. Husebekk, A., B. Skogen, G. Husby, and G. Marhaug. 1985. Transformation of amyloid precursor SAA to protein-AA and incorporation in amyloid fibrils in vivo. Scand. J. Immunol. 21: 283-287.
33. Tape, C., R. Tan, M. Nesheim, and R. Kisilevsky. 1988. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand. J. Immunol. 28: 317-324.
34. Urieli-Shoval, S., L. Reinhold, and M. Yaacov. 2000. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7: 64-69.
35. O'Hara, R., E. P. Murphy, A. S. Whitehead, O. FitzGerald, and B. Bresnihan. 2000. Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res. 2: 142-144.
36. Guo, J. T., J. Yu, D. Grass, F. C. de Beer, and M. S. Kindy. 2002. Inflammation-dependent cerebral deposition of serum amyloid A protein in a mouse model of amyloidosis. J. Neurosci. 22: 5900-5909.
37. Kindy, M. S., and F. C. de Beer. 1999. A mouse model for serum amyloid A amyloidosis. Methods Enzymol. 309: 701-704.
38. Solomon, A., D. T. Weiss, M. Schell, R. Hrncic, C. L. Murphy, J. Wall, M. D. McGavin, H. J. Pan, G. W. Kabalka, and M. J. Paulus. 1999. Transgenic mouse model of AA amyloidosis. Am. J. Pathol. 154: 1267-124.
39. Kindy, M. S., J. Yu, J. T. Guo, and H. Zhu. 1999. Apolipoprotein serum amyloid A in Alzheimer's disease. J. Alzheimers Dis. 1: 155-167.
40. Miyamae, T., D. E. Malehorn, B. Lemster, M. Mori, T. Imagawa, S. Yokota, W. L. Bigbee, M. Welsh, K. Klarskov, N. Nishomoto, et al. 2005. Serum protein protile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res. Ther. 7: R746-R755.
41. Strissel, K. J., M. T. Girard, J. A. West-Mays, W. B. Rinehart, J. R. Cook, C. E. Brinckerhoff, and M. E. Fini. 1997. Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. Exp. Cell Res. 237: 275-287.
42. Ray, A., H. Schatten, and B. K. Ray. 1999. Activation of Sp1 and its functional co-operation with SAF in synoviocyte cells trigger synergistic action of IL-1 and IL-6 in serum amyloid A gene expression. J. Biol Chem. 274: 4300-4308.
43. Kumon, Y., J. D. Sipe, C. E. Brinckerhoff, and B. M. Schreiber. 1997. Regulation of extrahepatic apolipoprotein serum amyloid A (ApoSAA) gene expression by interleukin-1 α alone: synthesis and secretion of ApoSAA by cultured aortic smooth muscle cells. Scand. J. Immunol. 46: 284-291.
44. Meek, R. L., S. Urieli-Shoval, and E. P. Benditt. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91: 3186-3190.
45. Thorn, C. F., Z.-Y. Lu, and A. S. Whitehead. 2003. Tissue-specific regulation of the human acute-phase serum amyloid A genes. SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells. Eur. J. Immunol. 33: 2630-2639.
46. Kumon, Y., T. Suehiro, D. J. Faulkes, T. Hosakawa, Y. Ikeda, P. Woo, J. D. Sipe, and K. Hashimoto. 2002. Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells. Scand. J. Immunol. 56: 504-511.
47. Betts, J. C., J. K. Cheshire, S. Akira, T. Kishimoto, and P. Woo. 1993. The role of NF-κB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem. 268: 25624-25631.
48. Ray, A., B. S. Bal, and B. K. Ray. 2005. Transcriptional induction of MMP-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between SAF-1 and AP-1. J. Immunol. 175: 4039-4048.
49. Ray, B. K., A. Shakya, J. R. Turk, A. S. Apte, and A. Ray. 2004. Induction of the MMP-14 gene in macrophages of the atherosclerotic plaque: role of SAF-1 in the induction process. Circ. Res. 95: 1082-1090.
50. Kovacevic, A., A. Hammer, M. Sundl, B. Pfister, A. Hrzenjak, A. Ray, B. K. Ray, W. Sattler, and E. Malle. 2006. Expression of serum amyloid A transcripts in human trophoblast and fetal-derived trophoblast-like choriocarcinoma cells. FEBS Lett. 580: 161-167.